GLP-1 agonist medications (semaglutide, tirzepatide) have changed the clinical landscape of weight management in ways that are still unfolding. The efficacy data is compelling; the long-term safety profile is still accumulating. At Diversity Healthcare, we prescribe GLP-1 medications for appropriate candidates within a supervised program that includes lifestyle counseling, metabolic monitoring, and ongoing clinical support. We are direct with patients about what the medication does, what it does not do, and what the discontinuation data shows about maintaining results.